|Articles|May 15, 2002
Researchers identify molecular target for diabetic retinopathy
Boston-Activation of vascular endothelial growth factor (VEGF) may initiate blood-retinal barrier breakdown during the onset of diabetes in rats. The VEGF activity seems to occur partly in the capillaries and venules of the superficial layer of the retina.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
2
Glaucoma innovation: Eight themes to watch in 2026
3
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
4
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
5








































